Barclays’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-82,074
| Closed | -$26M | – | 4331 |
|
|
2023
Q4 | $26M | Buy |
82,074
+8,152
| +11% | +$2.58M | 0.01% | 673 |
|
|
2023
Q3 | $12.5M | Sell |
73,922
-10,394
| -12% | -$1.76M | 0.01% | 803 |
|
|
2023
Q2 | $18.3M | Buy |
84,316
+55,707
| +195% | +$12.1M | 0.01% | 707 |
|
|
2023
Q1 | $5.2M | Sell |
28,609
-836
| -3% | -$152K | ﹤0.01% | 1065 |
|
|
2022
Q4 | $5.79M | Sell |
29,445
-1,653
| -5% | -$325K | ﹤0.01% | 1037 |
|
|
2022
Q3 | $6.99M | Buy |
31,098
+28,682
| +1,187% | +$6.45M | 0.01% | 947 |
|
|
2022
Q2 | $306K | Sell |
2,416
-7,493
| -76% | -$949K | ﹤0.01% | 2892 |
|
|
2022
Q1 | $1.26M | Sell |
9,909
-30,619
| -76% | -$3.88M | ﹤0.01% | 2128 |
|
|
2021
Q4 | $5.31M | Buy |
40,528
+21,575
| +114% | +$2.83M | ﹤0.01% | 1204 |
|
|
2021
Q3 | $2.32M | Buy |
18,953
+1,580
| +9% | +$193K | ﹤0.01% | 1752 |
|
|
2021
Q2 | $1.98M | Sell |
17,373
-12,930
| -43% | -$1.48M | ﹤0.01% | 1724 |
|
|
2021
Q1 | $3.64M | Sell |
30,303
-10,420
| -26% | -$1.25M | ﹤0.01% | 1421 |
|
|
2020
Q4 | $4.14M | Buy |
40,723
+32,476
| +394% | +$3.3M | ﹤0.01% | 1110 |
|
|
2020
Q3 | $637K | Sell |
8,247
-1,048
| -11% | -$80.9K | ﹤0.01% | 2181 |
|
|
2020
Q2 | $1.04M | Buy |
9,295
+5,496
| +145% | +$612K | ﹤0.01% | 1903 |
|
|
2020
Q1 | $274K | Sell |
3,799
-1,338
| -26% | -$96.5K | ﹤0.01% | 2406 |
|
|
2019
Q4 | $387K | Buy |
5,137
+2,879
| +128% | +$217K | ﹤0.01% | 2830 |
|
|
2019
Q3 | $37K | Buy |
+2,258
| New | +$37K | ﹤0.01% | 3748 |
|